Results 91 to 100 of about 1,721 (143)

Examination of the Suitability of Vericiguat in Non-Heart Failure with Preserved Ejection Fraction Patients with Improved Ejection Fraction

Background/Objectives: Vericiguat has been shown to reduce cardiovascular mortality and hospitalisation for heart failure in patients with reduced ejection fraction.
Chiemi Hirahara, Akiyo Suga, Mayumi Toko, Yoji Sumimoto, Haruyuki Kinoshita, Saki Ushirozako, Kenji Masada, Kento Fujita, Hiroshi Sugino, Kaori Taniyasu, Yumiko Katayama, Takashi Shimonaga, Masahiro Takada   +12 more
core   +1 more source

Short-term right heart reverse remodeling with vericiguat in HFrEF: reductions in pulmonary arterial pressure and chamber dimensions. [PDF]

Front Cardiovasc Med
Zhang Y, Zhang C, Tang C, Li H, Zhu J.
europepmc   +1 more source

Vericiguat in Elderly Patients with Heart Failure and Reduced Ejection Fraction: Clinical Perspectives from Pathophysiology to Implementation. [PDF]

J Clin Med
Rao CM, Lucà F, Ceravolo R, Gulizia MM, Gelsomino S, Ingianni N, Vatrano M, Chiappetta D, Scarpino T, Geraci G, Oliva F, Nardi F, Grimaldi M, Parrini I.   +13 more
europepmc   +1 more source

MASLD, HDL-C, Vericiguat. [PDF]

Anatol J Cardiol
Erol Ç.
europepmc   +1 more source

Incremental effects of vericiguat added to sacubitril/valsartan in heart failure with nonpreserved ejection fraction: a real-world study. [PDF]

Int J Cardiol Heart Vasc
Kinoshita H, Kimura K, Masada K, Shimonaga T, Sugino H.   +4 more
europepmc   +1 more source

Wenxin Keli, Clopidogrel, Vericiguat and New Impact Factor: 2.1. [PDF]

Anatol J Cardiol
Erol Ç.
europepmc   +1 more source

Vericiguat: The Fifth Pillar of Heart Failure. [PDF]

Rev Cardiovasc Med
Singh RB, Hadi NR, Shehab A, Elkilany G.
europepmc   +1 more source

Vericiguat in the Post-Stabilization Phase of HFrEF: Targeting Residual Risk Across the Ischemia-Decompensation Continuum. [PDF]

Int J Mol Sci
Krasińska B, Pisano C, Vazzana R, Raffa GM, Kowalewski M, Filipiak KJ, Bartkowski J, Krasiński Z, Suwalski P, Koziarska K, Nuzzi V, Manca P, Galasso G, Urbanowicz T.   +13 more
europepmc   +1 more source

Estimating the Benefits of the Comprehensive Disease-modifying Pharmacological Treatment in Patients with Heart Failure. [PDF]

Card Fail Rev
Escobar C, Caravaca-Pérez P, Fernandez-Rodriguez JM, Gomez-Otero I, Lozano-Bahamonde A, Pérez-Cabeza AI, Pérez-Silvestre J, Rafols C, Saldaña-García J, Esteban-Fernández A.   +9 more
europepmc   +1 more source

Effectiveness of vericiguat in heart failure across ejection fraction phenotypes: a comprehensive meta-analytic trial sequential analysis and meta-regression analysis. [PDF]

Ann Med Surg (Lond)
Khalil I, Islam MR, Das M, Promi SA, Al-Badri SG, Abrar S, Maliha AR, Debnath A, Islam ME, Mushfiquzzaman A, Hossain MI.   +10 more
europepmc   +1 more source